ABVC BioPharma (ABVC) Reports FY23, Provides Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. TECHM:IN
10. NVDA

Go back to ABVC BioPharma (ABVC) Reports FY23, Provides Operational Highlights

ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results

March 31, 2023 6:49 PM EDT

FREMONT, CA, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that seeks to deliver high efficacy and low toxicity to improve health outcomes, today announced its financial and operating results for the fiscal year ended December 31, 2022.

Full Year 2022 Financial Results

All comparisons are made on a year-over-year basis.

... More